Abstract
The nuclear structure for some target nuclei namely: 32S, 58Ni, 89Y, 90Zr, 100Mo and 197Au used for production of the therapeutic radionuclides; 32P, 58Co, 89Sr, 90Y, 99Mo, 100Tc, 197Pt and 197Hg has been investigated using Skyrme-Hartree-Fock method based on Skyrme effective two-body interaction. For these purpose, we have calculated the various nuclear densities, the corresponding root mean square radii and nuclear binding energies. The density dependent initial neutron and proton exciton numbers have been also calculated which give the ability to investigate the neutron and proton induced reaction cross-sections for these target nuclei using hybrid model for pre-equilibrium nuclear reactions. The calculated results are compared with available experimental data.
Highlights
IntroductionTheir major use is in medicine, in both diagnosis and therapy
In computing the observable charge densities using the SkyrmeHartree-Fock method (SHF) method, another fact should be considered that the nucleons themselves have intrinsic electromagnetic structure
Energies and rms radii of the selected target nuclei calculated using the SHF method with SkM parameterization are more close to the experimental data than that of the calculated results with the other Skyrme parameterizations
Summary
Their major use is in medicine, in both diagnosis and therapy. This work is to check whether the theoretical results obtainable by the SHF method for such nuclei will turn out to be conformant with the corresponding experimental data. For this purpose we have selected a number of target nuclides, namely: 32S, 58Ni, 89Y, 90Zr, 100Mo and 197Au for production therapeutic radionuclides; 32P, 58Co, 89Sr, 90Y, 99Mo and 197Pt. The proton, neutron, mass, and charge densities with their associated root mean square (rms) radii, nuclear binding energy (BE), initial exciton numbers and the nucleon-nucleon interaction cross section will be calculated. The calculated results will be compared with available experimental data
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
